Sunshine Biopharma Inc. (SBFM, SBFMW)
CIK 1402328 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Sunshine Biopharma Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 11, 2026 | 8-K | 0001683168-26-007090 |
| Sep 8, 2026 | EFFECT | 9999999995-26-002914 |
| Sep 8, 2026 | 424B3 | 0001683168-26-007017 |
| Aug 28, 2026 | S-1 | 0001683168-26-006779 |
| Aug 28, 2026 | 8-K | 0001683168-26-006777 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001079973-26-001125 |
| Aug 13, 2026 | SCHEDULE 13G/A | 0001213900-26-088834 |
| Aug 13, 2026 | 10-Q | 0001683168-26-006340 |
| Aug 11, 2026 | 4 | 0001683168-26-006206 |
| Aug 3, 2026 | 8-K | 0001683168-26-005899 |
| Jul 20, 2026 | 8-K | 0001683168-26-005656 |
| Jul 20, 2026 | 424B5 | 0001683168-26-005657 |
| Jul 10, 2026 | 8-K | 0001683168-26-005458 |
| Jul 8, 2026 | SCHEDULE 13G | 0001094891-26-000246 |
| Jun 8, 2026 | DEF 14C | 0001683168-26-004616 |
| May 29, 2026 | PRE 14C | 0001683168-26-004389 |
| May 29, 2026 | 8-K | 0001683168-26-004387 |
| May 22, 2026 | SCHEDULE 13G | 0001079973-26-000719 |
| May 21, 2026 | SCHEDULE 13G | 0000921895-26-001471 |
| May 19, 2026 | 424B4 | 0001683168-26-004098 |
| May 19, 2026 | 8-K | 0001683168-26-004116 |
| May 18, 2026 | EFFECT | 9999999995-26-001691 |
| May 13, 2026 | 10-Q | 0001683168-26-003819 |
| May 12, 2026 | S-1 | 0001683168-26-003726 |
| Apr 14, 2026 | 4 | 0001683168-26-002922 |